在心力衰竭中二次性症状的识别
Giulia Locatelli1, Diletta Fabrizi1, Davide Ausili1
1School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, Monza, Italy.
European journal of cardiovascular nursing
|March 29, 2025
概括
大多数心力衰竭患者-护理人员对象 (87%) 同意症状识别. 诸如护理人员的自我效能和患者的症状负担等因素影响了DYAD是否同意或不同意识别症状.
科学领域:
- 心脏病学 心脏病学
- 老年学是一门学科.
- 护理 护理 护理
背景情况:
- 心力衰竭 (HF) 管理依赖于自我护理,涉及患者和护理人员.
- 两次性症状的识别对于有效的HF自我护理至关重要,但研究不足.
- 了解患者和照顾者的症状协议可以优化干预措施.
研究的目的:
- 探索HF患者和护理人员之间症状识别的一致性/不一致性.
- 为了识别和和不和二度的特征.
- 为了确定二次性症状识别小组成员的预测因素.
主要方法:
- 从随机对照试验中对500个二二次分析.
- 根据症状识别项目分类为一致或不一致的二度.
- 多重逻辑回归用于识别二极性群体成员资格的预测因素.
主要成果:
- 87%的二元体表现出一致的症状识别.
- 患者自我护理 (SCHFI) 和护理人员贡献 (CC-SCHFI) 评分较差是常见的.
- 更高的护理人员自我效能预测了不一致的识别;更高的患者症状负担和认知障碍预测了一致的识别.
结论:
- 对应的症状识别在心力衰竭二元期中很普遍.
- 对一致和不一致的识别的预测因子不同,突出了不同的二动态.
- 研究结果支持针对个体和双层层次的症状识别和管理的定制策略.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Myocarditis II: Clinical Features and Diagnostic Tests
493
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493
Heart Failure III: Clinical Manifestations
1.2K
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation
1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790


